|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-5-10
|
|
pubmed:abstractText |
Reported overall survival (OS) rates of patients with localized Ewing sarcoma family of tumors (ESFT) are >80% when treated with the MSKCC P6 protocol. However, it has been associated with a 5.8% incidence of secondary leukemias. A modified P6 (mP6) protocol with reduced exposure to chemotherapy is presented.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1545-5017
|
|
pubmed:author |
pubmed-author:CardesaTeresaT,
pubmed-author:CruzOfeliaO,
pubmed-author:GalvánPatriciaP,
pubmed-author:HuguetRamonR,
pubmed-author:MoraJaumeJ,
pubmed-author:PararedaAndreuA,
pubmed-author:RodríguezEvaE,
pubmed-author:SalvadorHéctorH,
pubmed-author:SuñolMarionaM,
pubmed-author:TornerFerranF,
pubmed-author:de TorresCarmenC
|
|
pubmed:copyrightInfo |
Copyright © 2011 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
69-75
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21384537-Adolescent,
pubmed-meshheading:21384537-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21384537-Child,
pubmed-meshheading:21384537-Child, Preschool,
pubmed-meshheading:21384537-Cyclophosphamide,
pubmed-meshheading:21384537-Disease-Free Survival,
pubmed-meshheading:21384537-Doxorubicin,
pubmed-meshheading:21384537-Etoposide,
pubmed-meshheading:21384537-Female,
pubmed-meshheading:21384537-Follow-Up Studies,
pubmed-meshheading:21384537-Humans,
pubmed-meshheading:21384537-Ifosfamide,
pubmed-meshheading:21384537-Infant,
pubmed-meshheading:21384537-Male,
pubmed-meshheading:21384537-Neoplasm Metastasis,
pubmed-meshheading:21384537-Oncogene Proteins, Fusion,
pubmed-meshheading:21384537-Proto-Oncogene Protein c-fli-1,
pubmed-meshheading:21384537-RNA-Binding Protein EWS,
pubmed-meshheading:21384537-Recurrence,
pubmed-meshheading:21384537-Sarcoma, Ewing,
pubmed-meshheading:21384537-Survival Rate,
pubmed-meshheading:21384537-Vincristine
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents.
|
|
pubmed:affiliation |
Department of Oncology, Hospital Sant Joan de Déu, Barcelona, Spain. jmora@hsjdbcn.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
